drugset / Trial / NCT03016949

A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine

NCT03016949 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

The study will evaluate the humoral immunogenicity in various schedule combinations of full dose inactivated polio vaccines (IPV) via intramuscular administration (IM) and of the fractional dose of inactivated poliovaccine (f-IPV) via intradermal administration (ID).

Timeline

Start
2017-07
Primary completion
2018-10
Completion
2018-11

Outcome

Outcome not reported

Stopped: “Regulatory timelines for approval expired”

Drugs

EvaluationDrugModalityDoseRoute
Subject IPV Vaccine — Intramuscular
Subject f-IPV Vaccine — Other

Indications